These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1254965)

  • 1. The indiction by complement of a change in KSCN-dissociable red cell membrane lipids.
    Giavedoni EB; Dalmasso AP
    J Immunol; 1976 Apr; 116(4):1163-9. PubMed ID: 1254965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of erythrocyte membrane modulation by lysolecithin on complement-mediated lysis.
    Silverman BA; Weller PF; Shin ML
    J Immunol; 1984 Jan; 132(1):386-91. PubMed ID: 6690605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
    Packman CH; Rosenfeld SI; Weed RI; Leddy JP
    J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G; Opferkuch W
    J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
    Bauer J; Valet G
    J Immunol; 1983 Feb; 130(2):839-44. PubMed ID: 6848597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H; Okada N
    Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement.
    Lustig HJ; Bianco C
    J Immunol; 1976 Jan; 116(1):253-60. PubMed ID: 1245741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K; Whitlow MB; Nussenzweig V
    J Immunol; 1991 Oct; 147(8):2638-42. PubMed ID: 1918984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.
    Alving CR; Richards RL; Guirguis AA
    J Immunol; 1977 Jan; 118(1):342-7. PubMed ID: 830757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative complement pathway in bovine serum: lysis of human erythrocytes.
    Pang AS; Aston WP
    Am J Vet Res; 1977 Mar; 38(3):355-9. PubMed ID: 403835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.